Linkedin Facebook
Contact Us
Search
  • Technologies
  • Clinical Evidence
    • Landmark BIOADAPTOR RCT
    • Infinity-Swedeheart Clinical Trial​
    • Mechanistic Study of DynamX Bioadaptor
    • DESyne BDS Plus RCT
    • PINNACLE I Study for Intravascular Hertz Contact Lithotripsy
  • Videos
  • About Us
    • Management Team
    • News
  • Careers
Menu
  • Technologies
  • Clinical Evidence
    • Landmark BIOADAPTOR RCT
    • Infinity-Swedeheart Clinical Trial​
    • Mechanistic Study of DynamX Bioadaptor
    • DESyne BDS Plus RCT
    • PINNACLE I Study for Intravascular Hertz Contact Lithotripsy
  • Videos
  • About Us
    • Management Team
    • News
  • Careers
  • Technologies
  • Clinical Evidence
    • Landmark BIOADAPTOR RCT
    • Infinity-Swedeheart Clinical Trial​
    • Mechanistic Study of DynamX Bioadaptor
    • DESyne BDS Plus RCT
    • PINNACLE I Study for Intravascular Hertz Contact Lithotripsy
  • Videos
  • About Us
    • Management Team
    • News
  • Careers
  • Technologies
  • Clinical Evidence
    • Landmark BIOADAPTOR RCT
    • Infinity-Swedeheart Clinical Trial​
    • Mechanistic Study of DynamX Bioadaptor
    • DESyne BDS Plus RCT
    • PINNACLE I Study for Intravascular Hertz Contact Lithotripsy
  • Videos
  • About Us
    • Management Team
    • News
  • Careers
News

Elixir Medical Corporation Announces Outstanding 5-Year Clinical Data for CE Mark-Approved DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System

Read More
Share

Corporate Headquarters
920 N. McCarthy Blvd.
Milpitas, CA 95035 U.S.

+1.408.636.2000
info@elixirmedical.com

Elixir, Innovation for Life, DynamX, and DESyne are registered trademarks in the US and internationally for Elixir Medical Corporation.

DynamX Coronary Bioadaptor System and DESyne X2 Novolimus Eluting Coronary Stent System are CE Mark approved.

©2023-present Elixir Medical. All rights reserved.

International (OUS) Use Only. DynamX and DESyne X2 are intended to improve coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Sitemap
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Sitemap

 Site designed by The Deciding Factor